Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-13 Purchase | 2022-12-15 4:33 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 34,000 | $0.75409 | $25,639 | 282,444 (Indirect) | View |
| 2022-03-16 Purchase | 2022-03-17 7:10 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 49,038 | $1.5711 | $77,045 | 248,444 (Indirect) | View |
| 2019-06-06 Purchase | 2019-06-10 4:12 pm | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 25,500 | $3.4894 | $88,980 | 199,406 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-06 Option Award | 2023-12-08 4:08 pm | N/A 2033-12-06 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 6:49 pm | N/A 2032-08-11 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-09-09 Option Award | 2021-09-13 4:59 pm | N/A 2031-09-09 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:17 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:13 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |